Fundraising FoxACM BIOLABS
1 known investors
Find your way into ACM BIOLABS
Sign up to see every warm intro you have to ACM BIOLABS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ACM BIOLABS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ACM Biolabs develops a patent-protected polymer/lipid hybrid, non-viral drug delivery technology (ATP) that carries payloads such as oligonucleotides, small molecules, proteins, and mRNA to improve their efficacy. The company applies this platform to programs including a thermostable mRNA rabies vaccine and oncology immunotherapies targeting immunologically cold tumors.
Founders & leadership
MN
Madhavan NallaniFounder
Investors · 1
Frequently asked questions
- What does ACM BIOLABS do?
- ACM Biolabs develops a patent-protected polymer/lipid hybrid, non-viral drug delivery technology (ATP) that carries payloads such as oligonucleotides, small molecules, proteins, and mRNA to improve their efficacy. The company applies this platform to programs including a thermostable mRNA rabies vaccine and oncology immunotherapies targeting immunologically cold tumors.
- Who founded ACM BIOLABS?
- ACM BIOLABS was founded by Madhavan Nallani.
- Who are ACM BIOLABS's investors?
- ACM BIOLABS's investors include EFung Capital.